137 related articles for article (PubMed ID: 38445150)
1. Tuberculosis in a Liver Cirrhosis Patient: A Management Conundrum.
Diggikar PM; Reddy HR; Mundada M; Pancholi T; Faruqi AA
Cureus; 2024 Feb; 16(2):e53533. PubMed ID: 38445150
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.
Mishra S; Taneja S; De A; Muthu V; Verma N; Premkumar M; Duseja A; Singh V
J Clin Exp Hepatol; 2022; 12(2):278-286. PubMed ID: 35535073
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.
Sharma P; Tyagi P; Singla V; Bansal N; Kumar A; Arora A
J Clin Exp Hepatol; 2015 Mar; 5(1):8-13. PubMed ID: 25941429
[TBL] [Abstract][Full Text] [Related]
4. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
[TBL] [Abstract][Full Text] [Related]
5. A guide to the management of tuberculosis in patients with chronic liver disease.
Dhiman RK; Saraswat VA; Rajekar H; Reddy C; Chawla YK
J Clin Exp Hepatol; 2012 Sep; 2(3):260-70. PubMed ID: 25755442
[TBL] [Abstract][Full Text] [Related]
6. Anti-tuberculosis drug-induced liver injury in patient with hepatitis B and cirrhosis: A case report.
Aminy RZ; Kholili U
Ann Med Surg (Lond); 2022 Aug; 80():104154. PubMed ID: 36045776
[TBL] [Abstract][Full Text] [Related]
7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
8. Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis.
Tmu N; Kumar A; Sharma P; Singla V; Bansal N; Arora A
J Clin Exp Hepatol; 2019; 9(1):4-12. PubMed ID: 30765933
[TBL] [Abstract][Full Text] [Related]
9. Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury.
Huang D; Peng J; Lei L; Chen Y; Zhu Z; Cai Q; Deng Y; Chen J
J Clin Transl Hepatol; 2023 Apr; 11(2):425-432. PubMed ID: 36643044
[TBL] [Abstract][Full Text] [Related]
10. Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system.
Raj Mani SS; Iyyadurai R; Mishra AK; Manjunath K; Prasad J; Lakshmanan J; Yadav B; Reginald A; Jasmine S; Hansdak SG; Zachariah A
Int J Mycobacteriol; 2021; 10(2):116-121. PubMed ID: 34558461
[TBL] [Abstract][Full Text] [Related]
11. Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals.
Puri P; Kaur N; Pathania S; Kumar S; Sharma PK; Sashindran VK
Med J Armed Forces India; 2017 Jan; 73(1):12-17. PubMed ID: 28123239
[TBL] [Abstract][Full Text] [Related]
12. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: an observational study of 252 patients.
Upadhyay M; Patel J; Kundnani V; Ruparel S; Patel A
Eur Spine J; 2020 Jul; 29(7):1476-1482. PubMed ID: 32055960
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity and tuberculosis treatment outcomes in chronic liver disease.
Edwards BD; Mah H; Sabur NF; Brode SK
J Assoc Med Microbiol Infect Dis Can; 2023 Mar; 8(1):64-74. PubMed ID: 37008589
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.
Bolia R; Srivastava A; Yachha SK; Poddar U
J Hepatol; 2018 Mar; 68(3):449-455. PubMed ID: 29024698
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients.
Yimer G; Ueda N; Habtewold A; Amogne W; Suda A; Riedel KD; Burhenne J; Aderaye G; Lindquist L; Makonnen E; Aklillu E
PLoS One; 2011; 6(12):e27810. PubMed ID: 22162992
[TBL] [Abstract][Full Text] [Related]
18. When the Lightning Strikes Twice: Navigating the Complex Terrain of Cerebral Tuberculosis.
Sérvio R; Silva AR; Fernandes S; Tavares R; Rodrigues P
Cureus; 2024 Jan; 16(1):e52090. PubMed ID: 38344590
[TBL] [Abstract][Full Text] [Related]
19. Disease extent and anti-tubercular treatment response correlates with
Riou C; Du Bruyn E; Ruzive S; Goliath RT; Lindestam Arlehamn CS; Sette A; Sher A; Barber DL; Wilkinson RJ
Clin Transl Immunology; 2020; 9(9):e1176. PubMed ID: 33005414
[TBL] [Abstract][Full Text] [Related]
20. A Rare Case of Tubercular Osteomyelitis of Maxilla: A Case Report.
Shamanna K; Gopi R; Deshpande GA
Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):2477-2481. PubMed ID: 37636603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
